Browse studies
Find your next paid study
2 recruiting studies matching your filters
Phase 2
A Phase II Study of Ivonescimab as Monotherapy or in Combination With Platinum/Pemetrexed Chemotherapy in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) Harboring Actionable Genomic Alterations (AGAs)
The goal of this clinical trial is to assess the efficacy of ivonescimab monotherapy in patients with advanced non-small cell lung cancer harboring actionable …
Lung Cancer (NSCLC)Lung Cancer Non-Small Cell Cancer (NSCLC)Lung Cancer (Non-Small Cell)+3 more
Massachusetts General HospitalNCT07405190
Phase 1
A Multicenter, Open-label Phase 1/2 Dose Finding, Safety, and Pharmacokinetic Study of MBRC-201, an Antibody-drug Conjugate, in Advanced Refractory Solid Tumors
This is a multicenter, open-label FIH, Phase 1a (dose escalation), Phase 1b (dose expansion) and Phase 2 study in patients with advanced metastatic solid tumor…
Prostate Cancer Castration-resistant Prostate CancerBreast CancerColo-rectal Cancer+2 more
MBrace TherapeuticsNCT07145255